At a glance
ClinicalIndex Comparison RecordN/ACompleted· 300 enrolled
Drug / intervention
Midazolam injectiondrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Does Preoperative Midazolam Dose Affect Postoperative Pain? - a Multicentric Observational Study in Open Inguinal Hernia Repair
In Brief
An observational study evaluating Midazolam injection for Pain, Postoperative. Completed, enrolled 300 participants across 4 sites.
Detailed Summary
To investigate whether midazolam has any effect on postoperative pain in outpatient surgery, the investigators will assess the impact of different midazolam doses on pain scores 24h, 7 days and 3 months after open inguinal hernia repair. The investigators hypothesize that patients being administered higher midazolam doses will refer more pain.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Postoperative
CountriesPortugal
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedApr 2018
Enrollment StartSep 2018
Primary CompletionJun 2020
Study CompletionMar 2021
TodayJul 2026
First PostedApr 17, 2018
Enrollment StartSep 12, 2018
Primary CompletionJun 5, 2020
Study CompletionMar 5, 2021
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 8.2 years ago
Interventions
Midazolam injectiondrug
The dose of preoperative midazolam is the predictor variable and will be registered as a continuous variable in a single cohort.